Skip to content

Depression research published in 2023

Page 23 of 24: studies 441 to 460 of 466, newest first. Back to the depression overview

Studies

Mental stress, meditation, and yoga in cardiovascular and cerebrovascular diseases.

Brain circulation 2023 Aminah I Fayyaz, Yuchuan Ding 14 citations

It is well known that stress can increase the risk of heart attack and stroke although the exact way it does this is unknown. This information is particularly more relevant in a post COVID-19 era where healthcare workers are increasingly facing more stressful working conditions. Thus, it is important to look into alternative methods to deal with stress including meditation and yoga which have...

Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study.

Frontiers in Psychiatry 2023 Karl Kristjan Kaup, Madis Vasser, Kadi Tulver et al. 3 citations correction

Karl Kristjan Kaup1*, Madis Vasser1, Kadi Tulver1, Mari Munk2, Juhan Pikamäe1,3, Jaan Aru1*correcting author names or adding authors. Insert the correct version of the author list)1 Institute of Computer Science, University of Tartu, Estonia2 Psychiatry Clinic of North Estonia Medical Centre3 Institute of Molecular and Cell Biology, University of Tartu, Estonia* Correspondence:...

Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review.

Therapeutic Advances in Psychopharmacology 2023 Vivian W. L. Tsang, Brendan Tao, Shannon Dames et al. 19 citations

In the last few years, ketamine is becoming increasingly common in the treatment of mental health conditions, but there is a lack of safety data informing intramuscular and sublingual dosing in a community-focused group psychotherapy setting. The Roots To Thrive ketamine-assisted therapy (RTT-KaT) program is a unique 12-week RTT-KaT program with 12 community of practice (a form of group...

Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches.

Frontiers in Pain Research 2023 Daniella Batievsky, Michelle Weiner, Shari B Kaplan et al. 8 citations

Chronic pain and depression diagnoses are skyrocketing. There is an urgent need for more effective treatments. Ketamine was recently established to alleviate pain and depression, but many gaps remain in the scientific literature. This paper reports the findings of an observational preliminary study that explored the efficacy of ketamine-assisted psychotherapy (KAPT) for chronic pain/major...

Treatment of Mood and Depressive Disorders With Complementary and Alternative Medicine: Efficacy Review.

Journal of Midwifery & Women's Health 2023 Jasmine B R Cutler, Olivia Pane, Simran K Panesar et al. 30 citations

There has been a steady increase in people with symptoms of depression over the past several years (since 2011). The further increase in stress and depression in the early part of the COVID-19 pandemic was accompanied by an increase in unmet mental health needs. Many have turned to complementary and alternative medicine (CAM) therapies such as bright-light therapy, yoga, meditation, and dietary...

Effects of self-help mindfulness-based cognitive therapy on mindfulness, symptom change, and suicidal ideation in patients with depression: a randomized controlled study.

Frontiers in Psychology 2023 Yuanyuan Mo, Zhiying Lei, Mei Chen et al. 5 citations

This study aimed to evaluate the effects of self-help mindfulness-based cognitive therapy (MBCT-SH) on mindfulness, symptom change, and suicidal ideation in patients with depression. For this randomized controlled study, 97 patients were randomly assigned to either the MBCT-SH (n = 48) or control (n = 49) group. The Five Facet Mindfulness Questionnaire (FFMQ), Hamilton Depression Rating Scale...

The effectiveness of mindful hypnotherapy on difficulties in emotion regulation, mindfulness, and mental health in patients with major depressive disorder.

Journal of Education and Health Promotion 2023 Hassan Khazraee, Maryam Bakhtiari, Amir Sam Kianimoghadam et al. 6 citations

More than 300 million people are affected by major depressive disorder, and despite advances in treatments over the past 50 years, this number is increasing worldwide. Due to the high prevalence and increasing numbers, along with problems in various aspects of the patient's life, new effective treatments are essential in this field. This study was a single-blinded randomized clinical trial....

Overview of treatment-resistant depression.

Progress in Brain Research 2023 Cheng-Ta Li 25 citations

Patients with major depressive disorder (MDD) often exhibit an inadequate treatment response or failure to achieve remission following treatment with antidepressant drugs. Treatment-resistant depression (TRD) is proposed to identify this clinical scenario. Compared to those without TRD, patients with TRD have significantly lower health-related quality of life in mental and physical dimensions,...

The efficacy of mindfulness-based interventions on mental health among university students: a systematic review and meta-analysis.

Frontiers in Public Health 2023 Xinyi Zuo, Yong Tang, Yifang Chen et al. 56 citations

We aimed to estimate the effect of mindfulness therapy on mental health. Two researchers searched 12 databases to identify relevant trials that were published from 1 January 2018 to 1 May 2023. We performed a meta-analysis to determine the effect of mindfulness therapy on depression, which was measured by the Beck Depression Inventory (BDI), Patient Health Questionnaire-9 (PHQ-9), Quick...

Meta-analysis of a mindfulness yoga exercise intervention on depression - based on intervention studies in China.

Frontiers in Psychology 2023 Yuehang Yang, Dawei Cao, Teng Lyu et al. 15 citations

Using statistical methods to analyze and summarize the research data of the inclusion criteria, to provide a quantitative average effect size to interpret the influence of mindfulness yoga exercise on patients with different depressive symptoms, explain the therapeutic effect of mindfulness yoga therapy on depression and its possible mechanism of action, and provide new ideas for the clinical...

Effects of virtual reality guided meditation in older adults: the protocol of a pilot randomized controlled trial.

Frontiers in Psychology 2023 Karin Cinalioglu, Paola Lavín, Magnus Bein et al. 21 citations

Virtual reality (VR) based meditation has been shown to help increase relaxation and decrease anxiety and depression in younger adults. However, this has not been studied in Randomized Controlled Trials (RCT) in the older adult population. The aim of this RCT is to assess the feasibility and acceptability of a VR-guided meditation intervention for community-dwelling older adults and its effect...

Reducing cognitive arousal and sleep effort alleviates insomnia and depression in pregnant women with DSM-5 insomnia disorder treated with a mindfulness sleep program.

SLEEP Advances 2023 David A Kalmbach, Philip Cheng, Anthony N Reffi et al. 16 citations

Combining mindfulness with behavioral sleep strategies has been found to alleviate symptoms of insomnia and depression during pregnancy, but mechanisms for this treatment approach remain unclear. The present study examined nocturnal cognitive arousal and sleep effort as potential treatment mechanisms for alleviating insomnia and depression via a mindfulness sleep program for pregnant women....

Do yoga and meditation moderate the relationship between negative life events and depressive symptoms? Analysis of a national cross-sectional survey of Australian women.

Frontiers in Psychology 2023 Romy Lauche, Dennis Anheyer, Lisa A Uebelacker et al.

This study aims to examine the role of yoga/meditation in the relationship between negative life events, stress and depression. The Australian Longitudinal Study on Women's Health (ALSWH) surveyed 7,186 women aged 36-43 years (mean age 39.2 years; 57.2% university degree) in 2015. Mediation and moderation analyses were conducted to examine whether yoga/meditation practice moderated those...

Mindfulness-based cognitive therapy improves insomnia symptoms in individuals with recurrent depression: secondary analyses from a randomized controlled trial.

Frontiers in Psychiatry 2023 Linn Nyjordet Evanger, Elisabeth Flo-Groeneboom, Lin Sørensen et al. 9 citations

Embedded within a randomized efficacy trial, the present study aimed to investigate whether mindfulness-based cognitive therapy (MBCT) for recurrent depression improved symptoms of insomnia. Sixty-eight remitted participants with at least three prior episodes of depression were randomized to 8 weeks of MBCT (n = 33) or a waitlist control condition (n = 35). The Bergen Insomnia Scale was used to...

Role of yoga in stress management and implications in major depression disorder.

Journal of Ayurveda and Integrative Medicine 2023 53 citations

Major Depressive Disorder (MDD) is one of the leading causes of disability affecting more than 340 million people and second largest contributor to global burden of disease. Chronic stress is a common risk factor and important contributor for MDD. Stress could be defined as the "perceived inability to cope". Stressful life events are shown to provoke a sequence of psychological and...

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects.

Ibrain 2023 Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh et al. 27 citations

Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are the most common causes of emotional distress that impair an individual's quality of life. MDD is a chronic mental illness that affects 300 million people across the world. Clinical manifestations of MDD include fatigue, loss of interest in routine tasks, psychomotor agitation, impaired ability to focus, suicidal...

Evaluating passive physiological data collection during Spravato treatment.

Frontiers in Digital Health 2023 Todd M Solomon, Matus Hajduk, Martin Majernik et al. 1 citation

Spravato and other drugs with consciousness-altering effects show significant promise for treating various mental health disorders. However, the effects of these treatments necessitate a substantial degree of patient monitoring which can be burdensome to healthcare providers and may make these treatments less accessible for prospective patients. Continuous passive monitoring via digital devices...

Effects of Mindfulness-Based Interventions on Depression in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.

Integrative Cancer Therapies 2023 Chuntana Reangsing, Sasinun Punsuwun, Kristine Keller 21 citations

We examined the effects of Mindfulness-based interventions (MBIs) on depressive symptoms in women with breast cancer and examined the moderating effects of participant characteristics, research methodologies, and features of interventions. We systematically searched 12 databases through November 2022 without date restrictions using the following search terms: (mindful* or meditation) AND...

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada.

Frontiers in Psychiatry 2023 Carson Chrenek, Bryan Duong, Atul Khullar et al. 23 citations

Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to be efficacious for treatment-resistant depression (TRD), access to each of these treatments within healthcare systems is limited due to cost, availability, and/or monitoring requirements. IV ketamine has been offered at two public hospital sites in Edmonton, Canada since 2015. Since then, demand for maintenance...

DOI: 10.3389/fpsyt.2023.1283733 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Community ketamine use Maintenance ketamine Non-intravenous ketamine

Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.

Psychopharmacology 2023 Juliet Meccia, Joëlle Lopez, Rosemary C. Bagot 14 citations

Interest in the therapeutic potential of serotonergic psychedelic compounds including psilocybin has surged in recent years. While human clinical research suggests psilocybin holds promise as a rapid and long-lasting antidepressant, little is known about how its acute mechanisms of action mediate enduring alterations in cognition and behavior. Human neuroimaging studies point to both acute and...